A detailed history of State Of Alaska, Department Of Revenue transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 462,997 shares of BMY stock, worth $26.3 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
462,997
Previous 554,702 16.53%
Holding current value
$26.3 Million
Previous $23 Million 3.99%
% of portfolio
0.25%
Previous 0.26%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$39.66 - $51.75 $3.64 Million - $4.75 Million
-91,705 Reduced 16.53%
462,997 $24 Million
Q2 2024

Aug 05, 2024

BUY
$40.25 - $52.99 $2.11 Million - $2.78 Million
52,480 Added 10.45%
554,702 $23 Million
Q1 2024

Apr 19, 2024

SELL
$47.98 - $54.4 $2.26 Million - $2.56 Million
-47,130 Reduced 8.58%
502,222 $27.2 Million
Q4 2023

Jan 19, 2024

SELL
$48.48 - $57.85 $1.17 Million - $1.39 Million
-24,110 Reduced 4.2%
549,352 $28.2 Million
Q3 2023

Oct 16, 2023

SELL
$57.89 - $64.73 $563,269 - $629,822
-9,730 Reduced 1.67%
573,462 $33.3 Million
Q2 2023

Jul 24, 2023

BUY
$63.71 - $70.74 $865,181 - $960,649
13,580 Added 2.38%
583,192 $37.3 Million
Q1 2023

Apr 17, 2023

SELL
$65.71 - $74.53 $247,069 - $280,232
-3,760 Reduced 0.66%
569,612 $39.5 Million
Q4 2022

Jan 11, 2023

BUY
$68.48 - $81.09 $1.92 Million - $2.27 Million
28,029 Added 5.14%
573,372 $41.3 Million
Q3 2022

Oct 20, 2022

SELL
$0.13 - $76.84 $4,131 - $2.44 Million
-31,777 Reduced 5.51%
545,343 $38.8 Million
Q2 2022

Jul 08, 2022

BUY
$72.62 - $79.98 $4.08 Million - $4.5 Million
56,249 Added 10.8%
577,120 $44.4 Million
Q1 2022

Apr 14, 2022

BUY
$61.48 - $73.72 $3.99 Million - $4.78 Million
64,844 Added 14.22%
520,871 $38 Million
Q4 2021

Jan 12, 2022

SELL
$53.63 - $62.52 $2.17 Million - $2.53 Million
-40,480 Reduced 8.15%
456,027 $28.4 Million
Q3 2021

Oct 07, 2021

SELL
$59.17 - $69.31 $577,913 - $676,950
-9,767 Reduced 1.93%
496,507 $29.4 Million
Q2 2021

Jul 12, 2021

SELL
$61.91 - $67.42 $5.36 Million - $5.84 Million
-86,580 Reduced 14.6%
506,274 $33.8 Million
Q1 2021

Apr 09, 2021

SELL
$59.34 - $66.74 $2.22 Million - $2.49 Million
-37,350 Reduced 5.93%
592,854 $37.4 Million
Q4 2020

Jan 08, 2021

SELL
$57.74 - $65.43 $802,990 - $909,935
-13,907 Reduced 2.16%
630,204 $39.1 Million
Q3 2020

Oct 05, 2020

BUY
$57.43 - $63.64 $3.09 Million - $3.42 Million
53,799 Added 9.11%
644,111 $38.8 Million
Q2 2020

Jul 06, 2020

BUY
$54.82 - $64.09 $7.3 Million - $8.54 Million
133,185 Added 29.14%
590,312 $34.7 Million
Q1 2020

Apr 06, 2020

BUY
$46.4 - $67.43 $1.08 Million - $1.56 Million
23,194 Added 5.35%
457,127 $25.5 Million
Q4 2019

Jan 07, 2020

BUY
$49.21 - $64.19 $4.47 Million - $5.83 Million
90,843 Added 26.48%
433,933 $27.9 Million
Q3 2019

Oct 02, 2019

SELL
$42.77 - $50.71 $5.02 Million - $5.95 Million
-117,295 Reduced 25.48%
343,090 $17.4 Million
Q2 2019

Jul 23, 2019

BUY
$44.62 - $49.34 $942,240 - $1.04 Million
21,117 Added 4.81%
460,385 $20.9 Million
Q1 2019

Apr 09, 2019

BUY
$45.12 - $53.8 $8.86 Million - $10.6 Million
196,378 Added 80.85%
439,268 $21 Million
Q4 2018

Jan 10, 2019

BUY
$48.76 - $63.23 $189,432 - $245,648
3,885 Added 1.63%
242,890 $12.6 Million
Q3 2018

Oct 09, 2018

BUY
$55.19 - $62.25 $101,549 - $114,540
1,840 Added 0.78%
239,005 $14.8 Million
Q2 2018

Jul 10, 2018

BUY
$50.53 - $62.98 $2.4 Million - $2.99 Million
47,440 Added 25.0%
237,165 $13.1 Million
Q1 2018

Apr 19, 2018

BUY
$59.92 - $68.98 $1.8 Million - $2.07 Million
30,080 Added 18.84%
189,725 $12 Million
Q4 2017

Jan 19, 2018

BUY
$59.94 - $65.35 $8.84 Million - $9.63 Million
147,415 Added 1205.36%
159,645 $9.78 Million
Q3 2017

Oct 16, 2017

BUY
$55.23 - $63.74 $675,462 - $779,540
12,230
12,230 $778,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.